New guidance: Preoperative GLP-1s safe for surgical patients
Editor's Note Joint guidance from key US medical associations advises that most patients on GLP-1 weight-loss medications, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), may safely continue these drugs before surgery, HealthDay News reported October 31. Concerns had emerged about potential risks associated with these medications due to their…
How GLP-1 drugs impact health systems expansion, investment plans
Editor's Note A shuttered bariatric surgery center in Oklahoma last month is just one example of how the rise of Glucagon-like peptide-1 (GLP-1) agonists are reshaping health systems’ investments, Axios reported August 13. Rather than “massive hospital towers with cardiology clinics, dialysis beds and joint replacement centers,” the focus is…
Study: Routine ER screening catches undiagnosed type 2 diabetes, prediabetes
Editor's Note Early symptoms of type 2 diabetes often go undetected, and late detection can lead to long-term complications, including heart disease, nerve damage, and retinopathy. Screening for type 2 diabetes in the emergency department could reveal thousands of previously undiagnosed cases each year, EurekAlert! October 3 reports. These findings…
Free Daily News
- New guidance: Preoperative GLP-1s safe for surgical patients
- Study: Beta-blockers could increase postoperative stroke risk
- Music therapy reduces opioid use, anxiety in surgical patients
- Study: Poor sleep before surgery boosts risk of postoperative delirium
- GOP-controlled Senate to prioritize drug pricing, health agency reform
- Study links nurse burnout to lower patient safety, care quality
- Private Equity fuels growth of hospital-owned ASCs amidst rising demand, regulatory loopholes
- Outpatient facilities dominate healthcare construction as demand for community-based care grows
- OR Manager Conference session: Converting HOPDs to ASCs—What do hospitals need to know?
- AHA, FBI release resources to address targeted violence in healthcare